Warfarin was not more effective than aspirin and increased adverse events in symptomatic intracranial arterial stenosis
- Warfarin was not more effective than aspirin and increased adverse events in symptomatic intracranial arterial stenosis. Chimowitz, M. I.; Lynn, M. J.; Howlett-Smith, H. // Evidence Based Medicine;Oct2005, Vol. 10 Issue 5, p136
The article discusses whether aspirin is effective and safe for primary prevention of cardiovascular disease in women. Aspirin and warfarin did not differ for the primary composite endpoint or for death from vascular or non-vascular causes. Warfarin was associated with higher rates of all cause...
- Warfarin combined with low-dose aspirin in MI did not provide clinical benefit beyond that of aspirin alone. Oh, Vernon M. // ACP Journal Club;Sep/Oct2002, Vol. 137 Issue 2, p47
Compares the effect of warfarin combined with aspirin and aspirin alone on patients who have survived an acute myocardial infarction. Study design and main outcome measures; Intracranial hemorrhage rates; Information on bleeding occurrences in combination therapy.
- Choosing Anticoagulation or Aspirin After Heart Attack. Zepf, Bill // American Family Physician;3/15/2003, Vol. 67 Issue 6, p1349
Discusses the study 'Warfarin, Aspirin, or Both After Myocardial Infarction,' by M. Hurlen et al., from the September 26, 2002 issue of the 'New England Journal of Medicine.'
- ...but warfarin may outdo aspirin in preventing major vascular events among stroke-risk patients. // Modern Medicine;Oct95, Vol. 63 Issue 10, p6
Reports on the finding that patients with intracranial large-artery stenosis who take warfarin sodium prophylaxis appear to have a 46 percent less chance of stroke, myocardial infarction and sudden death than do patients who take aspirin. Rate of major vascular events in the warfarin and aspirin...
- Left ventricular function studied with MDCT. Juergens, Kai Uwe; Fischbach, Roman // European Radiology;Feb2006, Vol. 16 Issue 2, p342
Accurate determination of left ventricular (LV) myocardial function is fundamental for clinical diagnosis, risk stratification, and estimation of prognosis in patients with ischemic and nonischemic cardiomyopathy. Primarily, multi-detector-row spiral CT (MDCT) of the heart aimed at detecting...
- Long-term impact of multivessel disease on cause- specific mortality after ST elevation myocardial infarction treated with reperfusion therapy. Van Der Schaaf, R. J.; Timmer, I. R.; Ottervanger, J. P.; Hoorntje, J. C. A.; De Boer, M-J.; Suryapranata, H.; Zijlstra, F.; Dambrink, J. H. E. // Heart;Dec2006, Vol. 92 Issue 12, p1760
Objectives: To investigate the long-term impact of multivessel coronary artery disease (MVD) on cause- specific mortality in patients with ST elevation myocardial infarction (STEMI) treated with reperfusion therapy. Methods and results: Patients with STEMI (n = 395) treated with primary...
- Warfarin, acetylsalicylic acid or both? Hoey, John // CMAJ: Canadian Medical Association Journal;10/29/2002, Vol. 167 Issue 9, p1036
Examines drug therapies used in treatment of myocardial infarction including warfarin, acetylsalicylic acid (ASA), or aspirin, or both. Results of tests involving patients in all three drug therapies; Conclusions based on results show mortality across all three therapies were identical.
- An aspirin/warfarin cocktail prevents MIs. Cerrato, Paul L. // RN;Apr98, Vol. 61 Issue 4, p78
States that according to a large scale British trial which was conducted, the combination of aspirin and warfarin can reduce the risk of a first myocardial infarction by a third. Information on the reluctance by clinicians to combine the drugs; Details on the nature of drugs to cause bleeding.
- Clopidogrel Bisulfate In ST-Segment Elevation Myocardial Infarction: A Viewpoint by Steven R. Steinhubl. Steinhubl, Steven R // American Journal of Cardiovascular Drugs;2006, Vol. 6 Issue 6, p415
Ramipril is an oral, non-sulfhydryl ACE inhibitor thought to act in the renin-angiotensin-aldosterone system to decrease vasopressor activity, aldosterone secretion, and bradykinin degradation.Ramipril is generally well tolerated and effective in the treatment of patients aged â‰¥55 years at...